BRAF (V600E) kinase inhibitor RO5185426
| BRAF (V600E) kinase inhibitor RO5185426 | |
|---|---|
| Term | BRAF (V600E) kinase inhibitor RO5185426 |
| Short definition | BRAF (V600E) kinase inhibitor RO5185426 - drug used to treat Erdheim-Chester disease (a very rare form of histiocytosis) and advanced melanoma, which have a specific mutation (change) in melanomaBRAFGen. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
BRAF (V600E) kinase inhibitor RO5185426 - drug used to treat Erdheim-Chester disease (a very rare form of histiocytosis) and advanced melanoma, which have a specific mutation (change) in melanomaBRAFGen. It is also being studied in the treatment of other types of cancer. BRAF (V600E) kinase inhibitor RO5185426 blocks certain proteins produced by the mutationBRAFGene that can help stop cancer cells from growing. It's a kind of kinase inhibitor. Also called PLX4032, RG7204, vemurafenib and Zelboraf
External links
- Medical encyclopedia article on BRAF (V600E) kinase inhibitor RO5185426
- Wikipedia's article - BRAF (V600E) kinase inhibitor RO5185426
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski